CD274 and small cell lung carcinoma: Moreover, we failed to investigate the impact of ATB based on biomarkers, such as PD‐L1 expression, TMB and TILs, because the detection of these biomarkers was not mandatory for ES‐SCLC patients before they received ICIs, which might also skew the clinical responses and survival benefits.